Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Grand Pharmaceutical Group Limited ( (HK:0512) ) has shared an update.
Grand Pharmaceutical Group Limited, a company incorporated in Bermuda, has announced a proposed partial exercise of its right to acquire the remaining equity interest in Nanjing Kainite Medical Technology Company Limited. This acquisition involves an agreement with Nanjing Fund and Shanghai Hongsheng, based on a valuation of approximately RMB357 million. Upon completion, Grand Pharmaceutical will own 59.91% of the target company. This transaction is deemed a connected transaction under the company’s listing rules, requiring reporting and announcement but not a circular or independent shareholders’ approval.
More about Grand Pharmaceutical Group Limited
YTD Price Performance: -3.54%
Average Trading Volume: 2,778,015
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$16.75B
See more insights into 0512 stock on TipRanks’ Stock Analysis page.